Thymalfasin

thymosin alpha-1

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Thymalfasin, covering 2008-01-15 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma [Phase 2]

See pricing